1 1

Azarest 300mg tablet (azacitidine)

Azarest 300mg tablet (azacitidine)

Brand Name: Azarest 300 mg
Origin: Bangladesh
Small Orders: 1 pack / 14 tablets
Tags: Acute myeloid leukemia , AML , Anticancer Medicine , Azacitidine , Azacitidine 300 mg , Azarest 300 mg , Azarest Tablet , Bangladesh Medicine , Blood Cancer Treatment , Cancer Treatment , Everest Pharmaceuticals , film-coated tablet , Hematology , Hematology Medicine , Hypomethylating Agent , Leukemia Treatment , MDS , Myelodysplastic Syndrome , Nucleoside Metabolic Inhibitor , oncology , Oncology Medicine , Oral Cancer Medicine , Prescription Medicine , Targeted Cancer Therapy
View full details
  • Details
  • Description
Packaging Size: 14 tablets (1 × 14)
Strength: 300 mg
Composition: Azacitidine INN 300 mg per film-coated tablet
Treatment: Oral anticancer medicine used for certain myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) treatment settings. It is a nucleoside metabolic inhibitor that affects DNA/RNA methylation.
Form: Film-coated tablet
Brand: Azarest 300 mg
Quantity Unit: Tablet
Manufacturer: Everest Pharmaceuticals Ltd., Bangladesh

Azarest 300 mg Tablet (Azacitidine 300 mg) is an anticancer medicine containing azacitidine, a hypomethylating agent that affects abnormal DNA methylation and helps restore normal growth and maturation of blood-forming cells. It is used primarily for certain myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML), and acute myeloid leukemia (AML), depending on the specific formulation and treatment protocol. Azacitidine is generally administered under specialist supervision, and the appropriate route and dosage depend on the product and clinical indication.

Everyone Deserves Access to Life-saving Treatment Of Cancer. We are a Trusted Cancer Medicine seller delivering certified medications to every corner of the world.